In vitro study of the drug interactions between miglitol, an α-glucosidase inhibitor, and adsorbents

Yakugaku Zasshi

Volumn 127, Issue 12, 2007, Pages 2051-2055

  Amioka, Katsuo ^a   Wada, Ikuo ^b   Furuta, Yoshiyuki ^c  

^a KINJO GAKUIN UNIVERSITY   (Japan)

^b AOMORI UNIVERSITY   (Japan)

^c SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

Author keywords

Adsorbent; Drug interaction; In vitro; Miglitol

Indexed keywords

ADSORBENT; ALPHA GLUCOSIDASE INHIBITOR; CARBON; COLESTILAN; COLESTYRAMINE; MIGLITOL; POLYSTYRENESULFONATE CALCIUM; POLYSTYRENESULFONATE SODIUM; RESIN; SEVELAMER;

ARTICLE; CATION EXCHANGE; DOSE RESPONSE; DRUG ABSORPTION; DRUG RESEARCH; FOOD; HUMAN; IN VITRO STUDY; PH; SMALL INTESTINE;

1-DEOXYNOJIRIMYCIN; ADSORPTION; ALPHA-GLUCOSIDASES; CARBOHYDRATES; CARBON; CATION EXCHANGE RESINS; CHOLESTYRAMINE; DRUG INTERACTIONS; ENZYME INHIBITORS; EPICHLOROHYDRIN; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; IMIDAZOLES; IMINO PYRANOSES; POLYAMINES; POLYSTYRENES; RESINS, SYNTHETIC;

EID: 36849048299     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.2051     Document Type: Article

References (14)

1. Kosoglou T., Statkevich P., Johnson-Levonas A. O., Paolini J. F., Bergman A. J., Alton K. B., Clin. Pharmacokinet., 44, 467-494 (2005).
2. Takikawa H., Ogasawara T., Sato A., Ohashi M., Hasegawa Y., Hojo M., Int. J. Clin. Pharmacol. Ther., 39, 558-560 (2001).
3. Kays M. B., Overholser B. R., Mueller B. A., Moe S. M., Sowinski K. M., Am. J. Kidney Dis., 42, 1253-1259 (2003).
4. Belanger D. R., Tierney M. G., Dickinson G., Ann. Emerg. Med., 21, 1312-1315 (1992).
5. Toyoguchi T., Ebihara M., Ojima F., Hosoya J., Nakagawa Y., Biol. Pharm. Bull., 28, 841-844 (2005).
6. Kawai M., Takada M., Mitsuya M., Jpn. Pharmacol. Ther., 24, S607-611 (1996).
7. Suzuki K., Kawai M., Kaneko N., Shimada H., Jpn. Pharmacol. Ther., 29, 37-44 (2001).
8. Kuboyama N., Hayashi I., Yamaguchi T., Nippon Yakurigaku Zasshi, 127, 223-232 (2006).
9. Ahr H. J., BobergM., Brendel E., Krause H. P., Steinke W., Arzneim. -Forsch./Drug Res., 47, 734-745 (1997).
10. Matsumoto N., Kumai T., Tanaka M., Saitoh R., Kamio K., Takeba Y., Kobayashi S., Jpn J. Clin. Pharmacol. Ther., 34, 257S-258S (2003).
11. Hidaka M., Yamasaki K., Okumura M., Ogikubo T., Iwakiri T., Setoguchi N., Nishida K., Nagai K., Ikenoue T., Arimori K., Cancer Chemother. Pharmacol., 59, 321-328 (2007).
12. Honda Y., Nakano M., Jpn. J. Hosp. Pharm., 20, 265-272 (1994).
13. Myotoku M., Suyama T., Haji H., Jpn. J. Hosp. Pharm., 21, 483-487 (1995).
14. Scott L. J., Spencer C. M., Drugs, 59, 521-549 (2000).